BRIEF-Oncolytics Biotech® Provides Update On Intellectual Property Strategy And Patent Filings

Reuters01-08

BRIEF-<a href="https://laohu8.com/S/ONCWF">Oncolytics Biotech</a>® Provides Update On Intellectual Property <a href="https://laohu8.com/S/MSTR">Strategy</a> And Patent Filings

Jan 8 (Reuters) - Oncolytics Biotech Inc ONCY.O:

ONCOLYTICS BIOTECH® PROVIDES UPDATE ON INTELLECTUAL PROPERTY STRATEGY AND PATENT FILINGS
ONCOLYTICS BIOTECH INC - PLANS ADDITIONAL PATENT APPLICATIONS FOR PELAREOREP
ONCOLYTICS BIOTECH INC - TO PURSUE ADDITIONAL IP OPPORTUNITIES IN 2026

Source text: ID:nBw1Q05sla

Further company coverage: ONCY.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2601711360?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-08 22:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601711360","market":"nz","top_or_hot":-1,"title":"BRIEF-Oncolytics Biotech® Provides Update On Intellectual Property Strategy And Patent Filings","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ONCWF\">Oncolytics Biotech</a>® Provides Update On Intellectual Property <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> And Patent Filings</title></head><body><p><span>Jan 8 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/ONCY\">Oncolytics Biotech Inc</a> <span>ONCY.O</span>:</p><ul><li><p>ONCOLYTICS BIOTECH® PROVIDES UPDATE ON INTELLECTUAL PROPERTY STRATEGY AND PATENT FILINGS</p></li><li><p>ONCOLYTICS BIOTECH INC - PLANS ADDITIONAL PATENT APPLICATIONS FOR PELAREOREP</p></li><li><p>ONCOLYTICS BIOTECH INC - TO PURSUE ADDITIONAL IP OPPORTUNITIES IN 2026</p></li></ul><p>Source text: <span>ID:nBw1Q05sla</span></p><p>Further company coverage: <span>ONCY.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Oncolytics Biotech® Provides Update On Intellectual Property Strategy And Patent Filings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Oncolytics Biotech® Provides Update On Intellectual Property Strategy And Patent Filings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-08 22:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ONCWF\">Oncolytics Biotech</a>® Provides Update On Intellectual Property <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> And Patent Filings</title></head><body><p><span>Jan 8 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/ONCY\">Oncolytics Biotech Inc</a> <span>ONCY.O</span>:</p><ul><li><p>ONCOLYTICS BIOTECH® PROVIDES UPDATE ON INTELLECTUAL PROPERTY STRATEGY AND PATENT FILINGS</p></li><li><p>ONCOLYTICS BIOTECH INC - PLANS ADDITIONAL PATENT APPLICATIONS FOR PELAREOREP</p></li><li><p>ONCOLYTICS BIOTECH INC - TO PURSUE ADDITIONAL IP OPPORTUNITIES IN 2026</p></li></ul><p>Source text: <span>ID:nBw1Q05sla</span></p><p>Further company coverage: <span>ONCY.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA1STP79:1","article_id":"2601711360","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601711360","pubTimestamp":1767882311,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Oncolytics Biotech Provides Update On Intellectual Property Strategy And Patent FilingsJan 8 (Reuters) - Oncolytics Biotech Inc ONCY.O:ONCOLYTICS BIOTECH PROVIDES UPDATE ON INTELLECTUAL PROPERTY","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ONCY":"Oncolytics Biotech Inc"},"translate_title":"简介-溶瘤生物技术®提供知识产权战略和专利申请的最新信息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ONCY":0.9},"content_text":"BRIEF-Oncolytics Biotech® Provides Update On Intellectual Property Strategy And Patent FilingsJan 8 (Reuters) - Oncolytics Biotech Inc ONCY.O:ONCOLYTICS BIOTECH® PROVIDES UPDATE ON INTELLECTUAL PROPERTY STRATEGY AND PATENT FILINGSONCOLYTICS BIOTECH INC - PLANS ADDITIONAL PATENT APPLICATIONS FOR PELAREOREPONCOLYTICS BIOTECH INC - TO PURSUE ADDITIONAL IP OPPORTUNITIES IN 2026Source text: ID:nBw1Q05slaFurther company coverage: ONCY.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2601711360","isCrawlerRequest":true}